Skip to main content

Y-Intercept (Hong Kong) Ltd

Position in NVO — Novo Nordisk A S

CIK 1772875 HONG KONG, K3

Position in NVO

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$4,123,702
-$1,976,099 QoQ
Shares Held
86,018
-48.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#244
of 1,348 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $55,696,959 across 11 Drug Manufacturers - General names. NVO ranks #5 (7.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVO
Novo Nordisk A S
This page
86,018 $4,123,702

All Filings in NVO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,123,702 86,018
2026-03-31 $6,099,801 165,981
2025-12-31 $1,622,359 31,886
2025-09-30 $1,178,885 21,245
2025-06-30 $736,305 10,668
2025-03-31 $17,208,273 247,815
2024-12-31 $10,759,467 125,081
2024-09-30 $4,967,243 41,717
2024-03-31 $2,079,052 16,192
2023-12-31 $2,630,733 25,430
2023-09-30 $2,150,912 23,652
2023-06-30 $1,598,718 9,879
2022-06-30 $1,033,847 9,278
2021-09-30 $2,384,120 24,832
2021-03-31 $622,893 9,239
2020-12-31 $313,766 4,492